Gene-Tailored drugs show promise for rare salivary gland cancer
NCT ID NCT02069730
First seen Jan 11, 2026 · Last updated May 14, 2026 · Updated 15 times
Summary
This study looked at whether giving people with advanced salivary gland cancer a drug that matches their tumor's genetic makeup can help control the disease. 114 participants first had their tumor genes analyzed. If a targetable change was found, they got a matched drug; if not, they received a different drug called Selinexor. The goal was to see how many people's tumors shrank or stopped growing.
Disclaimer
Read more
Show less
This is a summary of
the original study
.
Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes no responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.
This is a summary of the original study . Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes no responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.
Get updates
Get notified about this study
Sign up to get updates when this study changes or when new studies for SALIVARY GLAND CANCER are added.
By submitting, you agree to our Terms of use
Contacts and locations
Show contact details
Enter your email to view the contact information for this study.
By submitting, you agree to our Terms of use
Locations
-
Princess Margaret Cancer Centre
Toronto, Ontario, M5G 2M9, Canada
Conditions
Explore the condition pages connected to this study.